Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
Clinical trial NCT05367440 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05367440
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2031-04-11
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.